Loco-regional therapies competing with radiofrequency ablation in potential indications for hepatocellular carcinoma: a network meta-analysis
Ha Il Kim, Jihyun An, Seungbong Han, Ju Hyun Shim
Clin Mol Hepatol. 2023;29(4):1013-1028.   Published online 2023 Jul 5     DOI: https://doi.org/10.3350/cmh.2023.0131
Citations to this article as recorded by Crossref logo
The Emerging Landscape for Combating Resistance Associated with Energy‐Based Therapies via Nanomedicine
Qitao Hu, Huali Zuo, Jessica C. Hsu, Cheng Zeng, Zhou Tian, Zhouyi Sun, Weibo Cai, Zhe Tang, Weiyu Chen
Advanced Materials.2024;[Epub]     CrossRef
Chemoembolization combined with radiofrequency ablation is the best option for the local treatment of early hepatocellular carcinoma?
Hyo-Cheol Kim
Clinical and Molecular Hepatology.2023; 29(4): 984.     CrossRef